| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 656755 | 64546 | CARTISORB 1500 mg POLVO PARA SOLUCION ORAL | CARTISORB 1500 mg POLVO PARA SOLUCION ORAL , 30 sobres | 1.500 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64546/64546_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64546/64546_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2002-02-04 | 1 | 1 | 1 | 2002-02-04 | 2008-03-14 | 1 | 2011-10-10 | 750307 | View Edit Delete | |||||||||||
| 728103 | 64538 | CEFTRIAXONA FRESENIUS KABI 1 G, POLVO PARA SOLUCION INYECTABLE INTRAVENOSA EFG | CEFTRIAXONA FRESENIUS KABI 1 G, POLVO PARA SOLUCION INYECTABLE INTRAVENOSA EFG , 10 viales | 1.000 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64538/64538_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64538/64538_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2002-02-04 | 1 | 1 | 1 | 2002-02-04 | 2020-02-28 | 0 | 2020-12-02 | View Edit Delete | ||||||||||||
| 728104 | 64539 | CEFTRIAXONA FRESENIUS KABI 2 g POLVO PARA SOLUCIÓN PARA PERFUSIÓN EFG | CEFTRIAXONA FRESENIUS KABI 2 g POLVO PARA SOLUCIÓN PARA PERFUSIÓN EFG,10 viales | 2.000 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64539/64539_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64539/64539_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2002-02-04 | 1 | 1 | 1 | 2002-02-04 | 2020-02-28 | 0 | 2020-12-02 | View Edit Delete | ||||||||||||
| 748970 | 64543 | DAIVOBET 50 microgramos/ 0,5 mg/g POMADA | DAIVOBET 50 microgramos/ 0,5 mg/g POMADA , 1 tubo de 60 g | 50 microgramos/g + 500 microgramos/g | 44 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64543/64543_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64543/64543_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8764 | LABORATORIOS LEO PHARMA S.A. | 2002-02-04 | 1 | 1 | 1 | 2002-02-04 | 2002-02-04 | 0 | 2011-09-08 | View Edit Delete | ||||||||||||
| 748368 | 64540 | CEFTRIAXONA FRESENIUS KABI 1 g POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE INTRAMUSCULAR EFG | CEFTRIAXONA FRESENIUS KABI 1 g POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE INTRAMUSCULAR EFG , 1 vial + 1 ampolla de disolvente | 1.000 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64540/64540_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64540/64540_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2002-02-04 | 1 | 1 | 1 | 2002-02-04 | 2002-02-04 | 0 | 2021-07-13 | View Edit Delete | ||||||||||||
| 763807 | 64551 | ZOLPIDEM NORMON 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ZOLPIDEM NORMON 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64551/64551_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64551/64551_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2002-02-04 | 1 | 1 | 1 | 2002-02-04 | 2023-11-28 | 1 | 2024-02-05 | Lista IV | View Edit Delete | |||||||||||
| 815241 | 64549 | CONDROSAN 400 mg CAPSULAS DURAS | CONDROSAN 400 mg CAPSULAS DURAS, 60 cápsulas | 400 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64549/64549_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64549/64549_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2002-02-04 | 1 | 1 | 1 | 2002-02-04 | 2002-02-04 | 0 | 2011-10-10 | View Edit Delete | ||||||||||||
| 816181 | 64551 | ZOLPIDEM NORMON 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ZOLPIDEM NORMON 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64551/64551_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64551/64551_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2002-02-04 | 1 | 1 | 1 | 2002-02-04 | 2002-02-04 | 1 | 2011-10-20 | Lista IV | View Edit Delete | |||||||||||
| 815217 | 64547 | CONDROSULF 400 mg CAPSULAS DURAS | CONDROSULF 400 mg CAPSULAS DURAS, 60 cápsulas | 400 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64547/64547_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64547/64547_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11580 | INSTITUTO BIOQUIMICO IBERICO IBSA S.L. | 2002-02-04 | 1 | 1 | 1 | 2002-02-04 | 2002-02-04 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 736066 | 00146022 | KEPPRA 1000 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | KEPPRA 1000 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 1.000 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/00146022/00146022_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/00146022/00146022_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8910 | UCB PHARMA S.A. | 2002-02-11 | 1 | 1 | 1 | 2002-02-11 | 2002-02-11 | 0 | 2012-01-09 | View Edit Delete | ||||||||||||
| 880740 | 01189001 | REPLAGAL 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | REPLAGAL 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 3,5 ml | 1 mg/ml inyectable 3,5 ml | 45 | 1 | 34 | 1 vial de 3,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01189001/01189001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01189001/01189001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 42050 | TAKEDA FARMACEUTICA ESPANA S.A. | 2002-02-11 | 1 | 1 | 1 | 2002-02-11 | 2002-02-11 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 697646 | 64560 | PROGEFFIK 200 mg CAPSULAS BLANDAS | PROGEFFIK 200 mg CAPSULAS BLANDAS , 60 cápsulas | 200 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64560/64560_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64560/64560_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7216 | LABORATORIOS EFFIK S.A. | 2002-02-13 | 1 | 1 | 1 | 2002-02-13 | 2013-04-12 | 1 | 2013-05-27 | View Edit Delete | ||||||||||||
| 819219 | 64560 | PROGEFFIK 200 mg CAPSULAS BLANDAS | PROGEFFIK 200 mg CAPSULAS BLANDAS , 15 cápsulas | 200 mg | 5 | 15 | 43 | 15 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64560/64560_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64560/64560_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7216 | LABORATORIOS EFFIK S.A. | 2002-02-13 | 1 | 1 | 1 | 2002-02-13 | 2002-02-13 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 608042 | 64566 | ESCOPOLAMINA B. BRAUN 0,5 mg/ml SOLUCIÓN INYECTABLE | ESCOPOLAMINA B. BRAUN 0,5 mg/ml SOLUCIÓN INYECTABLE , 100 ampollas de 1 ml | 0,5 mg/ml inyectable 1 ml | 1 | 100 | 1 | 100 ampollas de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64566/64566_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64566/64566_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 306 | B BRAUN MEDICAL S.A. | 2002-02-18 | 1 | 1 | 1 | 2002-02-18 | 2002-02-18 | 1 | 2020-03-11 | View Edit Delete | ||||||||||||
| 820589 | 64562 | LISINOPRIL CINFA 20 mg COMPRIMIDOS EFG | LISINOPRIL CINFA 20 mg COMPRIMIDOS EFG , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64562/64562_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64562/64562_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2002-02-18 | 1 | 1 | 1 | 2002-02-18 | 2002-02-18 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 820688 | 64563 | LISINOPRIL CINFA 5 mg COMPRIMIDOS EFG | LISINOPRIL CINFA 5 mg COMPRIMIDOS EFG , 60 comprimidos | 5 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64563/64563_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64563/64563_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2002-02-18 | 1 | 1 | 1 | 2002-02-18 | 2002-02-18 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 719797 | 64570 | NUVARING 0,120 mg/0,015 mg CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL | NUVARING 0,120 mg/0,015 mg CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL,1 dispositivo vaginal + un aplicador | 0,120 mg/24 h + 0,015 mg/24 h | 35 | 1 | 18 | 1 dispositivo vaginal + 1 aplicador | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64570/64570_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64570/64570_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35083 | ORGANON SALUD S.L. | 2002-02-21 | 1 | 1 | 1 | 2002-02-21 | 2017-11-15 | 0 | 2018-05-18 | View Edit Delete | ||||||||||||
| 823997 | 64571 | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64571/64571_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64571/64571_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 2002-02-21 | 1 | 1 | 1 | 2002-02-21 | 2002-02-21 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 825711 | 64578 | FUTURAN 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | FUTURAN 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 600 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64578/64578_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64578/64578_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2002-02-22 | 1 | 1 | 1 | 2002-02-22 | 2002-02-22 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 825992 | 64584 | DOLORAC 600 mg POLVO PARA SUSPENSION ORAL | DOLORAC 600 mg POLVO PARA SUSPENSION ORAL, 20 sobres | 600 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64584/64584_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64584/64584_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27143 | LABORATORIO DE APLICACIONES FARMACODINAMICAS S.A. | 2002-02-22 | 1 | 1 | 1 | 2002-02-22 | 2002-02-22 | 1 | 2020-10-19 | View Edit Delete |
Page 185 of 1035, showing 20 records out of 20697 total, starting on record 3681, ending on 3700